/>
top of page

Welcome!

Captario was founded on a mission to empower pharmaceutical businesses to make more proactive, fast, and insightful decisions. With a vision of revolutionizing pharma decision-making, Captario's focus has consistently been on developing our proprietary SaaS platform, Captario SUM®, supported by in-house scientific research on portfolio optimization to meet the goal of finding a more precise and straightforward solution to drug development modeling.

6-Minute Demo of Captario SUM®

The Customer Success Team

John_638x698.jpg

John McClure

Head of Client Solutions

john.mcclure@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
Anastasia Danopoulou (kopia).jpg

Anastasia Danopoulou

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
1671136794654.jpg

Anna Sarkisyan

Senior Data Analyst

anna.sarkisyan@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
BrookeDuffy__HiRes.jpg

Brooke Duffy

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
Stephanie_638x698 (kopia).jpg

Stephanie Mardini

Key Account Manager
stephanie.mardini@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
3.png

Liz Koch

Director, Demand Generation
liz.koch@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
1652465720847.jpg

Matthew Kokkonen

Director, Strategic Account Management
matthew.kokkonen@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
1649964619699.jpg

Kate Bernstein

Associate Quantitative Analyst

kate.bernstein@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
magnus_638x698 (kopia).jpg

Magnus Ytterstad

Portfolio Management Strategic Advisor

magnus.ytterstad@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
iStock-461202269.jpg
CASE STUDY

COVID-19 Portfolio Impact

Problem

A large pharma company with a robust clinical portfolio started seeing delays with no end to the COVID-19 pandemic in sight and wanted to understand the impact on portfolio value and risk.

Solution

Captario added delay scenarios in our system. Simulations were run with the delay across all projects set at 0, 3, 6, and 9 months and created a number of customized visualizations that specifically addressed the questions at hand. 

Captario's portfolio management solutions for drug development processes allow you to plan for "what-if" scenarios
bottom of page